Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
23 March 2012

IN THIS ISSUE
Teva warning letter
Ben Venue medicines
Sanofi plant closure
FDA Sentinel initiative


Teva warned for promotional materials
Teva Pharmaceuticals has received an FDA warning letter after promotional materials and an associated webpage for Copaxone were found to be false and misleading. More...
 
EMA says anticancer meds should move from Ben Venue Laboratories
The European Medicines Agency has recommended that manufacturing processes for two anticancer medicines be transferred from Ben Venue Laboratories to alternative facilities. More...
 
UK to fight Sanofi plant closure
Unite, Britain and Ireland’s largest trade union with 1.5 million members, intends to fight the closure of Sanofi’s pharmaceutical manufacturing facility in Newcastle-upon-Tyne. More...
 
FDA updates Sentinel initiative status
Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, has outlined the current status and future plans for the agency’s Sentinel Initiative, an electronic drug-safety tracking system. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
Key Topics:

Latest blog posts
AstraZeneca's Seroquel battle with FDA: a mark of desperation?
Biosimilars — it's the differences that really matter
International GMP collaboration
More blog posts

Latest articles
Single-use redundant filtration
Stepping up the fight against counterfeits
Parametric release and real-time release testing
More articles

Upcoming events
2012 PDA Annual Meeting (16–18 April | USA)
10th EGA International Symposium on Biosimilar Medicines (19–20 April | UK)
LogiPharma (24–26 April | Switzerland)
More events

Products/Service Profiles
Hospira One 2 One

Hospira One 2 One® contract development and fill-finish manufacturing of injectable products packaged in vials, PFS, cartridges, ampoules. Broad range of capabilities: Biologics; Potent drugs; Vaccines; Cytotoxics; Beta-lactams; Lyophilization.
Read more

 
New Mill

2-Day Webcast Auction Sale of Contract Pharmaceuticals Limited Niagara - April 18 & 19, Buffalo, NY, 500,000 Sq. Ft. Contract Processing & Packaging Facility.
Read more


Event Profile

10th EGA International Symposium on Biosimilar Medicines
19 – 20 April 2012
London
EGA's 10th anniversary international symposium in London has grown over the years to become the main annual get together for the biosimilars business in Europe. Read more

 

Pharma Outsourcing & Procurement Summit 2012
The Pharma Outsourcing and Procurement Summit 2012 addresses the urgent need for pharma to identify and locate the best outsourcing partnerships and solutions to stay competitive in an uncertain climate whilst addressing heightened regulatory pressures and need to maintain high quality standards. Read more

Survey
What does your company place the most emphasis on when analyzing tablet powder properties?
Particle characteristics 19%
 
Bulk powder properties 5%
     
Blend uniformity 25%
     
We consider these properties equally 51%

This week we would like to know...

What has been the most significant development in biologic-based drug manufacturing over the past 10 years?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.